Faecal calprotectin: a bright future for assessing disease activity in Crohn's disease

被引：12
|
作者：
Gaya, DR [1 ]
Mackenzie, JF [1 ]
机构：
[1] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
来源：
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2002年 / 95卷 / 09期
关键词：
D O I：
10.1093/qjmed/95.9.557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：557 / 558
页数：2
相关论文
共 50 条
  • [41] AUDIT AT ONE YEAR OF GUIDELINES FOR THE USE OF FAECAL CALPROTECTIN IN MONITORING CROHN'S DISEASE
    Turvill, J.
    Maxine, R.
    Rook, L.
    Robins, G.
    Kant, P.
    Smale, S.
    GUT, 2015, 64 : A231 - A232
  • [42] Faecal calprotectin as a non-invasive marker of Crohn's disease in anal fistulas
    Perregaard, Helene
    Pust, Freja
    Nordholm-Carstensen, Andreas
    COLORECTAL DISEASE, 2025, 27 (02)
  • [43] Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study
    Laharie, D.
    Mesli, S.
    El Hajbi, F.
    Chabrun, E.
    Chanteloup, E.
    Capdepont, M.
    Razaire, S.
    de Ledinghen, V.
    Zerbib, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (04) : 462 - 469
  • [44] Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
    Sipponen, T.
    Karkkainen, P.
    Savilahti, E.
    Kolho, K. -L.
    Nuutinen, H.
    Turunen, U.
    Farkkila, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (10) : 1221 - 1229
  • [45] Faecal calprotectin and plasma cytokines in the prediction of early postoperative Crohn's disease recurrence
    Cerrillo, E.
    Moret, I.
    Iborra, M.
    Hervas, D.
    Tortosa, L.
    Saez-Gonzalez, E.
    Nos, P.
    Beltran, B.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S257 - S257
  • [46] Does faecal calprotectin predict risk of relapse in Crohn's disease patients lacking objective clinical evidence of inflammatory disease activity?
    Watts, David A.
    Anderson, Norman
    Brydon, Gordon
    Satsangi, Jack
    Ghosh, Subrata
    GASTROENTEROLOGY, 2006, 130 (04) : A211 - A211
  • [47] Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
    Sipponen, Toino
    Savilahti, Erkki
    Kolho, Kaija-Leena
    Nuutinen, Hannu
    Turunen, Ulla
    Farkkila, Martti
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : 40 - 46
  • [48] Capsule Endoscopy Findings in Small Bowel Crohn's Disease Patients in Clinical Remission: Correlation With the Crohn's Disease Activity Index, Faecal Calprotectin and S100A12
    Aggarwal, Vipul
    Day, Andrew S.
    Connor, Susan J.
    Leach, Steven T.
    Grimm, Michael C.
    Craig, Philip I.
    GASTROENTEROLOGY, 2010, 138 (05) : S114 - S114
  • [49] Assessing disease activity in Crohn's disease - are we there yet?
    Eliakim, R
    Rachmilewitz, D
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (10) : 929 - 930
  • [50] Faecal calprotectin: a noninvasive marker of disease activity in inflammatory bowel disease
    Bokkers, R. P. H.
    van den Bergh, F. A. J. T. M.
    Kolkman, J. J.
    Russell, M. G. V. M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A1 - A1
12345